• LAST PRICE
    20.6600
  • TODAY'S CHANGE (%)
    Trending Up0.2400 (1.1753%)
  • Bid / Lots
    20.6400/ 1
  • Ask / Lots
    20.6700/ 1
  • Open / Previous Close
    20.2600 / 20.4200
  • Day Range
    Low 20.1700
    High 20.6800
  • 52 Week Range
    Low 12.3202
    High 32.1000
  • Volume
    122,219
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 20.42
TimeVolumeSAVA
09:32 ET326620.3
09:34 ET265120.29
09:36 ET210920.37
09:38 ET10020.3649
09:39 ET40020.3401
09:41 ET181520.3302
09:43 ET111020.4
09:45 ET336220.49
09:48 ET300520.52
09:50 ET140720.53
09:52 ET75020.4908
09:56 ET195620.36
09:59 ET40020.325
10:01 ET170020.4
10:03 ET50020.44
10:08 ET20020.43
10:10 ET107520.29
10:12 ET481220.24
10:14 ET85920.2
10:15 ET202820.1868
10:17 ET71020.17
10:19 ET248720.19
10:24 ET40020.25
10:26 ET10020.32
10:30 ET10020.32
10:35 ET60020.3792
10:37 ET40020.39
10:42 ET20020.42
10:44 ET10020.39
10:48 ET50020.43
10:51 ET2315320.4846
10:53 ET10020.49
10:55 ET179620.435
10:57 ET10020.41
11:00 ET10020.41
11:02 ET80020.365
11:04 ET41220.3467
11:06 ET30020.3714
11:09 ET50020.355
11:13 ET82220.42
11:15 ET24820.43
11:20 ET70020.46
11:22 ET60020.48
11:24 ET60020.46
11:26 ET216320.54
11:27 ET70020.58
11:29 ET120020.62
11:31 ET163520.66
11:33 ET363820.615
11:36 ET360020.5712
11:38 ET185020.62
11:40 ET227720.59
11:42 ET141820.64
11:44 ET160020.64
11:45 ET10020.62
11:47 ET20020.6497
11:49 ET94120.64
11:51 ET20020.6331
11:54 ET107520.6298
11:56 ET541120.64
11:58 ET426120.66
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSAVA
Cassava Sciences Inc
882.7M
-8.9x
---
United StatesCRGX
CARGO Therapeutics Inc
882.1M
-9.4x
---
United StatesELVN
Enliven Therapeutics Inc
870.1M
-8.4x
---
United StatesNUVB
Nuvation Bio Inc
869.6M
-10.7x
---
United StatesORIC
Oric Pharmaceuticals Inc
907.2M
-6.9x
---
United StatesTYRA
Tyra Biosciences Inc
856.1M
-9.9x
---
As of 2024-03-28

Company Information

Cassava Sciences, Inc. is a biotechnology company focused on Alzheimer's disease. The Company's science is based on stabilizing, but not removing, a critical protein in the brain. The Company is focused on its product discovery and development efforts on disorders of the nervous system. Its lead therapeutic drug candidate, simufilam, is under clinical evaluation for the proposed treatment of Alzheimer's disease dementia in Phase 3 clinical studies. The Company has two biopharmaceutical assets under development. Its lead therapeutic product candidate, called simufilam, is an oral treatment for Alzheimer's disease dementia. Its lead investigational diagnostic product candidate, called SavaDx, is a way to detect the presence of Alzheimer's disease from a small sample of blood. Simufilam targets an altered form of a protein called filamin A in the Alzheimer's brain. It owns rights to its drug and diagnostic assets and related technologies, without royalty obligations to any third party.

Contact Information

Headquarters
6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300AUSTIN, TX, United States 78731
Phone
512-501-2444
Fax
512-614-0414

Executives

Chairman of the Board, President, Chief Executive Officer
Remi Barbier
Chief Financial Officer
Eric Schoen
Senior Vice President, General Counsel
R. Christopher Cook
Chief Medical Officer
James Kupiec
Lead Independent Director
Sanford Robertson

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$882.7M
Revenue (TTM)
$0.00
Shares Outstanding
43.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
-0.44
EPS
$-2.32
Book Value
$3.25
P/E Ratio
-8.9x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.